BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7873531)

  • 1. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand.
    Anolik JH; Klinge CM; Hilf R; Bambara RA
    Biochemistry; 1995 Feb; 34(8):2511-20. PubMed ID: 7873531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA.
    Anolik JH; Klinge CM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):713-30. PubMed ID: 8274405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors.
    Anolik JH; Klinge CM; Brolly CL; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):413-29. PubMed ID: 9010347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements.
    Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R
    Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
    Klinge CM; Traish AM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):51-66. PubMed ID: 8645617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro.
    Klinge CM; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1992 Oct; 43(4):249-62. PubMed ID: 1390277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro.
    Klinge CM; Traish AM; Driscoll MD; Hilf R; Bambara RA
    Steroids; 1996 May; 61(5):278-89. PubMed ID: 8738832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
    Klinge CM
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Footprint analysis of estrogen receptor binding to adjacent estrogen response elements.
    Driscoll MD; Klinge CM; Hilf R; Bambara RA
    J Steroid Biochem Mol Biol; 1996 Apr; 58(1):45-61. PubMed ID: 8809185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression.
    Klinge CM
    Mol Cell Endocrinol; 1999 Apr; 150(1-2):99-111. PubMed ID: 10411304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro.
    Klinge CM; Peale FV; Hilf R; Bambara RA; Zain S
    Cancer Res; 1992 Mar; 52(5):1073-81. PubMed ID: 1737365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression.
    Klinge CM; Silver BF; Driscoll MD; Sathya G; Bambara RA; Hilf R
    J Biol Chem; 1997 Dec; 272(50):31465-74. PubMed ID: 9395481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro.
    Klinge CM; Brolly CL; Bambara RA; Hilf R
    J Steroid Biochem Mol Biol; 1997; 63(4-6):283-301. PubMed ID: 9459195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro.
    Klinge CM; Bodenner DL; Desai D; Niles RM; Traish AM
    Nucleic Acids Res; 1997 May; 25(10):1903-12. PubMed ID: 9115356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro interaction of uterine estrogen receptor with the estrogen response element present in the 3'-flanking region of the murine c-fos protooncogene.
    Hyder SM; Stancel GM
    J Steroid Biochem Mol Biol; 1994 Jan; 48(1):69-79. PubMed ID: 8136308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.
    Kumar V; Chambon P
    Cell; 1988 Oct; 55(1):145-56. PubMed ID: 3167974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence requirements for estrogen receptor binding to estrogen response elements.
    Driscoll MD; Sathya G; Muyan M; Klinge CM; Hilf R; Bambara RA
    J Biol Chem; 1998 Nov; 273(45):29321-30. PubMed ID: 9792632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes.
    Krieg AJ; Krieg SA; Ahn BS; Shapiro DJ
    J Biol Chem; 2004 Feb; 279(6):5025-34. PubMed ID: 14617632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen response element binding induces alterations in estrogen receptor-alpha conformation as revealed by susceptibility to partial proteolysis.
    Ramsey TL; Klinge CM
    J Mol Endocrinol; 2001 Dec; 27(3):275-92. PubMed ID: 11719281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.